Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2019 - 2025)
Vivos Therapeutics (VVOS) reported Non-Current Deffered Revenue of $1000.0 for Q3 2025, down 99.44% year-over-year from $178000.0 in Q3 2024, and down 80.0% on a QoQ basis from $5000.0 in Q2 2025.
Vivos Therapeutics (VVOS) has 7 years of Non-Current Deffered Revenue data on file, last reported at $1000.0 in Q3 2025.
- Quarterly Non-Current Deffered Revenue fell 99.44% year-over-year to $1000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1000.0 (down 99.44% YoY) and the FY2024 annual result came in at $97000.0, down 66.44% from the prior year.
- Non-Current Deffered Revenue fell to $1000.0 in Q3 2025 per VVOS's latest filing, from $5000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $533000.0 in Q1 2024 and bottomed at $1000.0 in Q3 2025.
- The 5-year median for Non-Current Deffered Revenue is $250000.0 (2023), against an average of $236235.3.
- The widest annual swing landed in 2023, when Non-Current Deffered Revenue soared 158.04%; it then sank 99.44% in 2025.
- Tracing VVOS's Non-Current Deffered Revenue over 5 years: stood at $343000.0 in 2021, then sank by 67.35% to $112000.0 in 2022, then soared by 158.04% to $289000.0 in 2023, then tumbled by 66.44% to $97000.0 in 2024, then sank by 98.97% to $1000.0 in 2025.
- Per Business Quant, the three latest VVOS Non-Current Deffered Revenue figures stand at $1000.0 (Q3 2025), $5000.0 (Q2 2025), and $22000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 289,000.00 |
| Sep 30, 2023 | 240,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 180,000.00 |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 375,000.00 |
| Dec 31, 2021 | 343,000.00 |
| Sep 30, 2021 | 360,000.00 |
| Jun 30, 2021 | 358,395.00 |
| Mar 31, 2021 | 212,076.00 |
| Dec 31, 2020 | 146,000.00 |
| Dec 31, 2019 | 84,246.00 |